Staging for Melanoma - Toward a New Paradigm?
Menée à partir de données portant sur 1 315 patients atteints d'un mélanome de stade I à III, cette étude compare la précision de la 7ème et de la 8ème édition du système de stadification de l'"American Joint Committee on Cancer" pour établir un pronostic
In this issue of the Journal, Bajaj and colleagues present an assessment of the accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition melanoma staging system(AJCC8) 1. Their study was prompted by concerns that implementation of AJCC8 might disrupt analysis of active clinical trials for Stage III patients, largely because of perceived difficulty of comparing patients staged according to AJCC8versus previous systems. The authors reanalyzed1357 Stages I-III patientsfrom AJCC7 into AJCC8, concludingthat AJCC8 enabled a more accurate prognosis, andalsothat restaging a large cohort of patients was not only possible but could enhance the analysis of active clinical trials.
Journal of the National Cancer Institute , éditorial en libre accès, 2019